FF vs RARE · rev $110.7M vs rev $350.0M
FutureFuel Corp (FF) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
FutureFuel Corp (FF) is a specialty chemicals company listed on NYSE.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported FF revenue for 2026-06-30 was $110.7M. Net income was -$9.2M. FF currently screens at market cap $185.5M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
FF currently screens at market cap $185.5M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the FF and RARE stock pages for the full models.
Not investment advice.